Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Decentralized, Randomized, Active-Controlled Clinical Trial Investigating the Effects of NT-II™ (Salmon Undenatured Type II Collagen) on Activity-Related Knee Discomfort and Functional Performance in Healthy Adults

NCT07119645 is registered in ClinicalTrials.gov with Hofseth Biocare ASA as lead sponsor.

NCT NCT07119645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07119645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Decentralized, Randomized, Active-Controlled Clinical Trial Investigating the Effects of NT-II™ (Salmon Undenatured Type II Collagen) on Activity-Related Knee Discomfort and Functional Performance in Healthy Adults
Lead sponsor
Hofseth Biocare ASA
Phase
Not applicable
Overall status
Recruiting
Start date
January 20, 2025
Completion date
October 15, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

activity-related knee discomfort, functional joint pain, functional knee pain, joint discomfort, knee acute and chronic pain